Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 323.20M | € 374.50M | € 787.50M | € 403.70M | € 361.90M |
Total Assets | € 2.88B | € 2.95B | € 2.47B | € 2.08B | € 1.88B |
Total Debt | € 976.60M | € 1.00B | € 983.20M | € 724.50M | € 703.10M |
Net Debt | € 653.40M | € 629.10M | € 195.70M | € 320.80M | € 341.20M |
Total Liabilities | € 1.96B | € 2.18B | € 1.76B | € 1.48B | € 1.35B |
Stockholders Equity | € 918.80M | € 773.30M | € 699.30M | € 596.30M | € 521.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |